SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Google

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Heart failure linked to heavy energy drink consumption
Fri April 16th - Drinking excessive energy drinks could be linked to a young man’s heart failure, according to doctors who treated a 21-year-old who consumed four cans a day for two years. More
Shift workers' heart health linked to body clock
Fri April 16th - The risk of heart disease becomes greater the more an individual works outside of their natural body clock, new research suggests. More
Infection much greater risk than vaccines for thrombotic events
Fri April 16th - Cerebral venous thrombosis has been a significant complication of COVID-19 at a rate far higher than seen after vaccination, British researchers have reported. More
RECENT COMMENTS
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
OUR CLIENTS
THIS WEEK'S STORIES
ENGLEMED HEALTH NEWS

SARS treatments could work for new Middle East virus

Tuesday September 17th, 2013

Treatments that worked on the SARS coronavirus are the key for the development of therapies for the lethal Middle East Respiratory Syndrome Coronavirus (MERS-CoV), it has been claimed.

A paper published in the International Journal of Infectious Diseases looks at the different treatment models of SARS and concludes that because of their similarities, treatments that worked on SARS corona virus will also work for the newly discovered strain.

It is therefore important that people with the MERS-CoV should be identified and treated before they have chance to infect others.

Dr Eskild Petersen, of Aarhus University, Denmark, and journal editor, said: “The publication of this paper is important and particularly timely because the two viruses are similar and there is a high probability that a treatment which worked for SARS, also could work for MERS-CoV.

“Providing a review of published treatment series for SARS will make it much easier to determine possible treatments for MERS-CoV and avoid treatments which do not work.”

MERS-CoV, was first found a year ago in a patient who died but it took several months before it was discovered that a new virus had emerged.

New cases have been reported from Jordan, Qatar, Saudi Arabia, and the United Arab Emirates, while France, Germany, Italy, Tunisia and the United Kingdom have reported imported cases coming from the Middle East. The virus has since been identified in just over 90 patients, more than half of whom have died from the infection.

Momattin H, Mohammed K et al. Therapeutic Options for novel Coronavirus infections including Middle East Respiratory Syndrome Coronavirus (MERS-CoV) - possible lessons from a systematic review of SARS therapy. International Journal of Infectious Diseases. September 2013. DOI 10.1016/j.ijid.2013.07.002). [abstract]

Tags: Asia | Europe | Flu & Viruses | Respiratory

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES